Search research articles
Contact Us
Filters
Showing results (61-70 of 104) with videos related to
Page
of 11
Sort By:
Molecular Psychiatry
|
June 4, 2014
Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients
J Frank, M Lang, S H Witt, et al.
Translational Psychiatry
|
June 14, 2017
The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
A Kautzky, G M James, C Philippe, et al.
Molecular Psychiatry
|
January 31, 2003
No association of alcohol dependence with a NMDA-receptor 2B gene variant
G Schumann, D Rujescu, A Szegedi, et al.
Genes, Brain, and Behavior
|
January 25, 2011
Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder
E Stergiakouli, K Langley, H Williams, et al.
Translational Psychiatry
|
October 14, 2015
Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia
A Ingason, I Giegling, A M Hartmann, et al.
Acta Psychiatrica Scandinavica
|
October 7, 2018
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
A Kautzky, M Dold, L Bartova, et al.
The Pharmacogenomics Journal
|
March 18, 2009
Association of nicotinic acetylcholine receptor subunit alpha 4 polymorphisms with nicotine dependence in 5500 Germans
L P Breitling, N Dahmen, K Mittelstrass, et al.
Molecular Psychiatry
|
October 30, 2013
Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci
J Gelernter, H R Kranzler, R Sherva, et al.
Acta Psychiatrica Scandinavica
|
November 22, 2007
Is MAO-B activity in platelets associated with the occurrence of suicidality and behavioural personality traits in depressed patients?
U Lewitzka, B Müller-Oerlinghausen, W Felber, et al.
Der Nervenarzt
|
February 1, 2018
[Pharmacogenetics in psychiatry: state of the art]
D J Müller, E J Brandl, F Degenhardt, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 104) with videos related to
Sort By:
Page
of 11
Molecular Psychiatry
|
June 4, 2014
Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients
J Frank, M Lang, S H Witt, et al.
Translational Psychiatry
|
June 14, 2017
The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
A Kautzky, G M James, C Philippe, et al.
Molecular Psychiatry
|
January 31, 2003
No association of alcohol dependence with a NMDA-receptor 2B gene variant
G Schumann, D Rujescu, A Szegedi, et al.
Genes, Brain, and Behavior
|
January 25, 2011
Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder
E Stergiakouli, K Langley, H Williams, et al.
Translational Psychiatry
|
October 14, 2015
Expression analysis in a rat psychosis model identifies novel candidate genes validated in a large case-control sample of schizophrenia
A Ingason, I Giegling, A M Hartmann, et al.
Acta Psychiatrica Scandinavica
|
October 7, 2018
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
A Kautzky, M Dold, L Bartova, et al.
The Pharmacogenomics Journal
|
March 18, 2009
Association of nicotinic acetylcholine receptor subunit alpha 4 polymorphisms with nicotine dependence in 5500 Germans
L P Breitling, N Dahmen, K Mittelstrass, et al.
Molecular Psychiatry
|
October 30, 2013
Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci
J Gelernter, H R Kranzler, R Sherva, et al.
Acta Psychiatrica Scandinavica
|
November 22, 2007
Is MAO-B activity in platelets associated with the occurrence of suicidality and behavioural personality traits in depressed patients?
U Lewitzka, B Müller-Oerlinghausen, W Felber, et al.
Der Nervenarzt
|
February 1, 2018
[Pharmacogenetics in psychiatry: state of the art]
D J Müller, E J Brandl, F Degenhardt, et al.
Page
of 11